Harvard Bioscience Inc (HBIO) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $8.05 (+0.25%), Market cap $0.02B, 52-week low–high $0.28 ~ $7.24.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular
Financial statements, price targets, institutional (13F) holdings and related news for Harvard Bioscience Inc are updated in real time on BlackAll Trade.
Harvard Bioscience Inc trades at $8.05 (+0.25%). Real-time quotes and charts are available on BlackAll Trade.
Harvard Bioscience Inc has a market cap of about $0.02B.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationall